United Community Bank Alnylam Pharmaceuticals, Inc. Transaction History

United Community Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 13, 2024	SELL	$185.01 - $212.05 $74,189 - $85,032	-401 Closed	0 $0
Q3 2022 Feb 13, 2024	BUY	$138.54 - $232.0 $2,770 - $4,640	20 Added 5.25%	401 $80.3 Million
Q2 2022 Feb 13, 2024	BUY	$120.42 - $169.29 $1,324 - $1,862	11 Added 2.97%	381 $55.6 Million
Q1 2022 Feb 13, 2024	BUY	$127.18 - $173.91 $635 - $869	5 Added 1.37%	370 $60.4 Million
Q4 2021 Feb 13, 2024	BUY	$159.56 - $209.29 $58,239 - $76,390	365 New	365 $61.9 Million

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of United Community Bank, based on Form 13F filings with the SEC.

Stay updated on United Community Bank with notifications on news.